Till sidinnehåll

Bilaga 5 – Nordic protocol for neuropsychological follow-up of children treated for brain tumor – revision 2023

Pediatric brain tumor is a rare and heterogeneous disease and neurocognitive sequelae are common, which makes standardized neuropsychological follow-up and collaborative data collection crucial.

This is a common Nordic Test protocol, developed and agreed upon by Nordic neuropsychologists working with children with cancer. The protocol is updated continuously and is in line with the recommendations from the SIOP-Europe brain tumor working group.1,2

This protocol is recommended for all children, diagnosed with a brain tumor at age 0-18 years, regardless of type and grade of tumor, or any related syndromes.* Neuropsychological assessment is recommended at diagnosis, two, and five years after diagnosis (+/- 3 months). Individual rehabilitation needs often require further assessments, e.g., earlier than 2 years post-diagnosis, into teenage years, or at school transitions. The core battery is a minimum, and extended assessment is most often required to design rehabilitation interventions and to fully map the individual’s neurocognitive profile. Recording of obtained data in national registries (when available) is recommended. Tests can be administered digitally or in a paper-pencil-version.

This protocol, or an abbreviated version of it, could also be used for survivors of non-CNS childhood cancer at risk for neurocognitive sequelae, i.e., survivors treated with cranial radiation therapy, total body irradiation, stem cell transplant, or intrathecal or high-dose intravenous methotrexate.3

Domain

Core battery (0 to 18 years)

Age span (years)

Supplementary list

Motor speed

 

 

Grooved Pegboard (from age 5) or other pegboard test

Processing speed

Wechsler Coding (age- appropriate Wechsler-test)

4–18

 

Wechsler Symbol Search (age- appropriate Wechsler-test)

4–18

 

Verbal skills

Wechsler Vocabulary (age- appropriate Wechsler-test)

4–18

 

Wechsler Similarities (age- appropriate Wechsler-test)

4–18

 

WPPSI Picture Naming/Bayley expressive language

0–4

 

WPPSI Receptive Vocabulary/Bayley receptive language

0–4

 

Fluid intelligence/ spatial perceptual intelligence

Wechsler Matrix (age- appropriate Wechsler-test)

4–18

 

Wechsler Block Design (age- appropriate Wechsler-test)

2.5–18

 

Working memory

Digit span (age-appropriate Wechsler-test)

6–18

Wechsler Picture Memory (from age 2.5)

Visual-motor integration

Beery-Buktenica VMI 6,
full form

2–18

 

Sustained attention

Conner’s CPT III

8–18

 

Executive function

D-Kefs TMT
Verbal fluency (D-Kefs
or Nepsy, from age 3)

8–18

D-Kefs Color Word, Tower

Memory

 

 

Word list (Nepsy, Rey Auditory Verbal Learning Test, California Verbal Learning Test)

General cognitive ability

 

 

Bayley Scales of Infant Development Cognitive Index
Full scale IQ require the following tests, additional to the core battery: WPPSI-IV 2.5–3 years: Information, Picture Memory, Object Assembly WPPSI-IV: Picture memory
WISC-V: Figure Weights
WAIS-IV: Arithmetic or Letter Number Sequencing, Visual Puzzles or Figure
Weights, Information

*Children with brain tumors due to Neurofibromatosis (NF) or Tuberous sclerosis (TS) are included if/when also diagnosed with brain tumor. Children with spinal tumors are excluded, except if the tumors are infiltrating the medulla.

Questionnaires

Core battery (2 to 18 years)

Health related quality of life

PedsQL generic core scale and multidimensional fatigue scale or PROMIS Scales generic and fatigue scales. Proxy and self-report (when available)

Executive function:
Behavior

3–18 years: Behavior Rating Inventory of Executive Function
Proxy and self-report (when available)

  1. Limond J, Thomas S, Bull KS, et al: Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years. Eur J Paediatr Neurol 25:59-67, 2020
  2. Limond JA, Bull KS, Calaminus G, et al: Quality of survival assessment in European childhood brain tumour trials, for children aged 5 years and over. Eur J Paediatr Neurol 19:202-10, 2015
  3. Nathan PC, Patel SK, Dilley K, et al: Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med 161:798-806, 2007